Neuroanatomical and functional characterization of CRF neurons of the amygdala using a novel transgenic mouse model by De Francesco, Pablo et al.
Neuroscience 289 (2015) 153–165NEUROANATOMICAL AND FUNCTIONAL CHARACTERIZATION OF
CRF NEURONS OF THE AMYGDALA USING A NOVEL TRANSGENIC
MOUSE MODELP. N. DE FRANCESCO, a S. VALDIVIA, a A. CABRAL, a
M. REYNALDO, a J. RAINGO, b I. SAKATA, c,d
S. OSBORNE-LAWRENCE, c,d J. M. ZIGMAN c,d AND
M. PERELLO´ a*
a Laboratory of Neurophysiology, Multidisciplinary Institute of Cell
Biology [Argentine Research Council (CONICET) and Scientiﬁc
Research Commission, Province of Buenos Aires (CIC-PBA)], La
Plata, Buenos Aires, Argentina
b Laboratory of Electrophysiology, Multidisciplinary Institute of
Cell Biology [Argentine Research Council (CONICET) and
Scientiﬁc Research Commission, Province of Buenos Aires
(CIC-PBA)], La Plata, Buenos Aires, Argentina
cDivision of Hypothalamic Research and Division of
Endocrinology and Metabolism, Department of Internal
Medicine, University of Texas Southwestern Medical Center, Dallas,
TX, United States
dDepartment of Psychiatry, University of Texas Southwestern
Medical Center, Dallas, TX, United StatesAbstract—The corticotropin-releasing factor (CRF)-produc-
ing neurons of the amygdala have been implicated in behav-
ioral and physiological responses associated with fear,
anxiety, stress, food intake and reward. To overcome the dif-
ﬁculties in identifying CRF neurons within the amygdala, a
novel transgenic mouse line, in which the humanized
recombinant Renilla reniformis green ﬂuorescent protein
(hrGFP) is under the control of the CRF promoter (CRF-
hrGFP mice), was developed. First, the CRF-hrGFP mouse
model was validated and the localization of CRF neurons
within the amygdala was systematically mapped. Amygdalar
hrGFP-expressing neurons were located primarily in the
interstitial nucleus of the posterior limb of the anterior com-
missure, but also present in the central amygdala. Secondly,
the marker of neuronal activation c-Fos was used to explore
the response of amygdalar CRF neurons in CRF-hrGFP mice
under diﬀerent experimental paradigms. C-Fos induction
was observed in CRF neurons of CRF-hrGFP mice exposed
to an acute social defeat stress event, a fasting/refeedinghttp://dx.doi.org/10.1016/j.neuroscience.2015.01.006
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153paradigm or lipopolysaccharide (LPS) administration. In
contrast, no c-Fos induction was detected in CRF neurons
of CRF-hrGFP mice exposed to restraint stress, forced
swimming test, 48-h fasting, acute high-fat diet (HFD) con-
sumption, intermittent HFD consumption, ad libitum HFD
consumption, HFD withdrawal, conditioned HFD aversion,
ghrelin administration or melanocortin 4 receptor agonist
administration. Thus, this study fully characterizes the dis-
tribution of amygdala CRF neurons in mice and suggests
that they are involved in some, but not all, stress or food
intake-related behaviors recruiting the amygdala.
 2015 IBRO. Published by Elsevier Ltd. All rights reserved.
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INTRODUCTION
The neuropeptide corticotropin-releasing factor (CRF)
plays a key role in controlling homeostatic balance (Vale
et al., 1983; Carlin et al., 2006). It is well known that
CRF regulates the rapid mobilization of resources and
behaviors in response to stress, as well as other impor-
tant central functions including food intake and autonomic
nervous system activity (Vale et al., 1983; Carlin et al.,
2006). CRF neurons are concentrated in the hypotha-
lamic paraventricular nucleus (PVN), and include the
hypophysiotropic CRF neurons of the hypothalamic–pitu-
itary–adrenal (HPA) neuroendocrine axis which becomes
activated in response to stress (Bale and Vale, 2004).
CRF neurons are also found in extra-hypothalamic
regions of the central nervous system including the cere-
bral cortex, basal ganglia, amygdala, thalamus, hippo-
campus, and spinal cord (Swanson et al., 1983). Among
the extra hypothalamic sites, CRF neurons are particu-
larly enriched in the amygdala, which is part of complex
neural circuitries that regulate a variety of behavioral
and autonomic responses activated when animals are
exposed to stress, fear or rewarding stimuli (Gray, 1999;
Baxter and Murray, 2002; Sah et al., 2003). Surprisingly,
knowledge about the CRF neurons of the amygdala is
rather limited due to diﬃculties in identifying these neu-
rons in rodents. Furthermore, while the distribution of
CRF neurons of the amygdaloid complex in the rat has
been characterized quite extensively (Cassell et al.,
1986; Sakanaka et al., 1986; Marchant et al., 2007), stud-
ies on the localization of these neurons in mice are few
and mainly focused on the central amygdala (CeA)
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neuronal cell bodies by immunohistochemistry requires
colchicine pre-treatment, which alters normal brain phys-
iology and severely limits its study in normal conditions
(Asan et al., 2005). In recent years, several eﬀorts have
been made to facilitate the identiﬁcation of CRF neurons
by means of transgenic mouse models (Alon et al.,
2009; Martin et al., 2010; Wamsteeker Cusulin et al.,
2013; Gaﬀord et al., 2014; Itoi et al., 2014). However,
these studies were mainly focused on CRF neurons of
the PVN, and little information is provided about the distri-
bution or function of these cells in the amygdaloid
complex.
To overcome this issue and get insights into the CRF
neurons of the amygdala, a novel transgenic reporter
mouse, in which humanized recombinant Renilla
reniformis green ﬂuorescent protein (hrGFP) is under
the control of the CRF promoter, was generated. The
CRF-producing cells in this transgenic mouse model,
named CRF-hrGFP mice, are marked by ﬂuorescent
signal and are easily identiﬁable. Taking advantage of
this mouse model, the distribution of CRF neurons
within the mouse amygdala was fully characterized.
Notably, a number of experimental conditions are known
to activate the amygdala and presumably involve CRF-
mediated responses. However, the technical diﬃculties
for the identiﬁcation of CRF neurons in a physiologically
intact context have precluded the possibility to test
whether the CRF neurons of the amygdala indeed
participate in such circuits. To this end, the CRF-hrGFP
transgenic mouse line was used to map the induction of
c-Fos within the CRF neurons of the amygdala in order
to explore the functional role of amygdalar CRF neurons
in diﬀerent experimental conditions known to activate
this brain region.EXPERIMENTAL PROCEDURES
Generation of CRF-hrGFP transgenic mice
A line of transgenic mice that express hrGFP eutopically
within CRF-producing cells was generated for this study.
These animals were made through the use of various
ET-cloning ‘‘recombineering’’ technologies (Lee et al.,
2001; Muyrers et al., 2001). The original CRF bacterial
artiﬁcial chromosome (BAC) was purchased from BAC-
PAC Resources Center at Children’s Hospital Oakland
Research Institute and was chosen based on sequence
data obtained from the Celera database. This CRF
BAC, named RP24-80I22, contained nearly 92.64 kb
sequence upstream of the CRF start codon and the entire
coding sequence of CRF, ending 38.16 kb downstream
of the CRF stop codon. The RP24-80I22 CRF BAC was
transformed by electroporation into EL250 cells, which
contain heat-inducible recE and recT recombinases, for
homologous recombination, and arabinose-inducible
Flp-recombinase, for site-speciﬁc recombination at FRT
sites (Lee et al., 2001). Next, a fragment containing the
coding sequence of hrGFP followed by an SV40 polyade-
nylation signal (derived from the phrGFP-1 vector, Strata-
gene, La Jolla, CA, USA) and a kanamycin resistance gene
ﬂanked by FRT sites was inserted into the RP24-80I22CRF BAC, at the translational start site of CRF, by
ET-cloning. This insertion resulted in the removal of the
564-bp of CRF’s coding sequence. Finally, the kanamycin
resistance gene was removed by arabinose induction of
Flp-recombinase, and the hrGFP was sequenced to
ensure that no mutations had been introduced. The
hrGFP-modiﬁed RP24-80I22 CRF BAC was submitted
to UTSW Medical Center Transgenic Core Facility for
microinjection into pro-nuclei of fertilized one-cell stage
embryos of C57BL/6J mice. We were successful in gener-
ating seven diﬀerent potential CRF-hrGFP founder mice,
of which one resulted with the expected and abundant
hrGFP expression within the amygdala. The CRF-hrGFP
mice used in this study were on a pure C57BL/6J genetic
background. Animals were housed under a 12:12-h light/
dark cycle in a temperature-controlled environment. They
were fed standard regular chow diet and had free access
to water, except when indicated. Regular chow contains
2.5 kcal/g energy, of which 3.6 g% are from fat. High-fat
diet (HFD) contains 3.9 kcal/g energy, of which 21.1 g%
are from fat. Diets were provided by Gepsa Feeds (Grupo
Pilar S.A., Pilar, Buenos Aires, Argentina). This study was
carried out in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals
of the National Research Council, USA, and all eﬀorts
were made to minimize suﬀering. All experimentation
received approval from the Institutional Animal Care and
Use Committee of the IMBICE.
Validation of CRF-hrGFP transgenic mice
In order to validate the transgenic mouse model, coronal
brain sections of CRF-hrGFP mice were used to perform
CRF immunohistochemistry. Double immunostaining was
performed in brain samples from either:1-naı¨ve CRF-
hrGFP mice (n= 3); 2-CRF-hrGFP mice intra-
cerebroventricularly (ICV, coordinates AP: 0.3 mm, L:
1.0 mm and V: 2.3 mm) injected with colchicine (32 lg
in 4 lL) 72-h before sacriﬁce (n= 3); and 3-CRF-
hrGFP mice bilaterally injected with colchicine (3.2 lg in
0.4 lL) into the amygdala using the stereotaxic
coordinates AP:-1.2 mm, L: -2.4 mm and V:4.0 mm,
72-h before sacriﬁce (n= 3). Anesthetized mice were
perfused with heparinized phosphate-buﬀered saline
(PBS) and then with 4% formaldehyde in PBS. Brains
were removed, post-ﬁxed, immersed in 20% sucrose/1%
formalin, and cut coronally at 42 lm into three equal
series on a sliding cryostat. Then, sections were
washed, treated with blocking solution (3% normal
donkey serum and 0.25% Triton X-100 in PBS), and
incubated with a goat anti-CRF antibody (Santa Cruz,
Dallas, TX, USA, No. sc-1759, lot K1104, 1:200) for two
days at 4 C. Then, sections were washed and treated
with Alexa-594 donkey anti-goat antibody (Molecular
Probes, Life Technologies, Carlsbad, CA, USA, cat#
A11058, 1:1000) overnight. Consecutively, sections
were washed, sequentially mounted on glass slides, and
coverslipped with mounting media. Fluorescent images
were acquired with a Nikon Eclipse 50i and a DS-Ri1
Nikon digital camera. Then, the total number of green
ﬂuorescent- and/or red ﬂuorescent-labeled cells was
quantiﬁed through the whole amygdala.
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characterization of the distribution of hrGFP neurons
within the amygdala
In order to describe the rostro-caudal volumetric
distribution of the hrGFP neurons throughout the whole
amygdala, sequential coronal brain sections from a
CRF-hrGFP mouse were mounted on glass slides,
coverslipped with mounting media, and then
microphotographed using an epiﬂuorescence
microscope to record hrGFP ﬂuorescence in the region
of the amygdala and photographed under a binocular
magniﬁer with oblique white illumination to obtain the
gross anatomy. Registration and alignment of both
image sets was performed in a semi-automated fashion
using Fiji (Schindelin et al., 2012) and TrakEM2
(Cardona et al., 2012). For each image pair, the position
of every hrGFP-positive cell was recorded, and the main
anatomical features (borders, tracts, commissures) were
delineated. Using this information a 3D model of each rel-
evant feature was constructed in Fiji with the 3D Viewer
plugin and imported into Blender (http://www.blender.
org/) for volumetric representation.
In an independent study, anesthetized CRF-hrGFP
mice (n= 4) were perfused, and their brains processed
as described above in order to obtain four equal series
per animal. One series of each mouse was mounted
and used to visualize cytoarchitecture; in this case,
brain sections were stained with thionin (cat# T7029;
Sigma–Aldrich, St. Louis, MO, USA), dehydrated in an
ascending alcohol series, cleared in xylene and
coverslipped. Another series of each mouse was
mounted, cover slipped and used to detect hrGFP
ﬂuorescence using an epiﬂuorescence microscope, as
described above. A third series of each mouse was
used to detect hrGFP-immunoreactive (IR) cells; in this
case, brain sections were pretreated with 1% H2O2,
treated with blocking solution (3% normal donkey serum
and 0.25% Triton X-100 in PBS), and incubated with
rabbit polyclonal anti-hrGFP antibody (Stratagene, La
Jolla, CA, USA, cat# 240142, 1:1000) for 2 days at 4 C.
Then, sections were treated with biotinylated donkey
anti-rabbit antibody (Jackson ImmunoResearch
Laboratories, West Grove, PA, USA, 1:1,000) for 1 h,
and with Vectastain Elite ABC kit (Vector Laboratories,
Burlingame, CA, USA) for 1 h, according to the
manufacturer’s protocols. Then, visible signal was
developed with 3-30-diaminobenzidine (DAB), giving a
brown precipitate. All samples were microphotographed
and used for neuroanatomical characterization of the
distribution of the hrGFP neurons within the amygdala.
For the analysis, the amygdala was subdivided into the
following regions: (1) the basolateral amygdala (BLA);
(2) the interstitial nucleus of the posterior limb of the
anterior commissure (IPAC), which is a brain nucleus
that lies at the junction of the striato-pallidal system and
the lateral bed nucleus of the stria terminalis-central
amygdaloid complex; and (3) the CeA. The brain slices
were analyzed in a systematic manner rostro-caudally
from bregma coordinates 0.25 to 1.81 mm, and three
levels, at bregma 0.22, 0.58 and 1.46 mm, were
chosen as representative of the anterior, middle andposterior levels of the amygdala, respectively.
Neuroanatomical limits were deﬁned as described in the
mouse brain atlas (Paxinos and Franklin, 2001). In order
to estimate the total number of hrGFP-IR cells in the
amygdala, we quantiﬁed cells containing distinct cytoplas-
mic light brown chromogen reaction product in one out of
four complete series of coronal sections through the
whole nuclei. Then, these numbers were summed and
multiplied by four. The data were corrected for double
counting, according to the method of Abercrombie
(Abercrombie, 1946), where the ratio of the actual number
of neurons to the observed number is represented by T/
T+ h where T= section thickness, and h= the mean
diameter of the neuron. For this, hrGFP-IR cell diameter
was quantiﬁed, of at least 40 cells in each brain area
and experimental group, using Fiji.
Experimental protocols
In order to get insights into the role of CRF neurons of the
amygdala, diﬀerent cohorts of 2–3-month-old male CRF-
hrGFP mice weighting 20–25 g, were single housed and
exposed to a series of experimental manipulations are
described below. Importantly, at least two diﬀerent trials
were performed for each experimental paradigm.
(1) Bacterial lipopolysaccharide (LPS) treatment: On
the experimental day, fresh solutions of LPS
(25 lg/mouse, cat# L-3755; Sigma–Aldrich, St.
Louis, MO, USA) were prepared with sterile endo-
toxin-free isotonic PBS as a vehicle and intraperito-
neally (i.p.) administered to CRF-hrGFP mice
(n= 4). Control mice were i.p. injected with vehicle
alone (n= 3). Mice were anesthetized 2 h after
treatment and perfused. This dose of LPS was cho-
sen based on the basis of its ability to induce the
activation of the immune system and an acute sick-
ness response including fever, suppression of loco-
motor activity, anorexia, among other, which has
been showed by our and others’ studies (Kozak
et al., 1994; Perello´ et al., 2011; Walker et al.,
2013). Importantly, a similar dose of LPS has been
shown to induce c-Fos expression in the amygdala
of mice (Tarr et al., 2012; Skelly et al., 2013).
(2) Acute social defeat stress: This test is based upon
the resident–intruder paradigm, in which an experi-
mental mouse is introduced into the home cage of a
diﬀerent mouse for a short-time physical encounter.
This test was performed using an acute version of
our previously published protocol (Chuang et al.,
2011). Resident mice were aggressive 1-year-
old, 50 g, C57BL/6J breeders selected for their
attack latencies, of less than 30 s, upon three con-
secutive screening tests. For the encounter, exper-
imental CRF-hrGFP mice were introduced for
10 min in a cage where the resident mouse had
been housed for 1 week. During the exposure, all
defeated CRF-hrGFP mice showed signs of stress
and subordination, including vocalization, ﬂight
response, and submissive posture. Following this
exposure, CRF-hrGFP mice were returned to their
home cages and perfused 2 h later (n= 5).
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bite marks or wounds. Importantly, a similar proto-
col of social defeat paradigm has been shown to
activate neurons of the amygdala in rats (Martinez
et al., 1998).
(3) Fasting/refeeding paradigm: Individually housed
mice were fasted by removing their food from the
home cages at 9:00 am. After 48 h, mice were
either perfused (n= 4) or given access to food for
2 h and then perfused (n= 5). Food intake was
recorded and veriﬁed to be increased in the refeed-
ing group as compared to non-fasted mice. Impor-
tantly, this paradigm has been shown to induce
c-Fos expression in the amygdala in mice (Wu
et al., 2014).
(4) Acute HFD: In the morning of the experimental day,
mice were exposed to HFD ad libitum (n= 5) and
perfused after 2 h of food consumption, which was
veriﬁed to increase compared to mice exposed to
regular chow. Of note, satiated mice were exposed
to HFD in the morning, at a time of the day when
spontaneous food intake is minimal, and while they
remained with free access to regular chow because
we have recently shown that acute HFD consump-
tion is mainly due to the palatable nature of the stim-
ulus and recruit centers of the mesolimbic pathway
including neurons of the amygdala (Valdivia et al.,
2014).
(5) Intermittent HFD: In the morning, mice were given
HFD ad libitum for 2 h during four consecutive days
(n= 6). Their HFD intake was recorded and veri-
ﬁed to escalate over successive days (Berner
et al., 2008). Animals were perfused 2 h post last
HFD consumption. As explained above, these
experiments were performed during the morning
because HFD consumption is mainly driven by
hedonic aspects of eating and involves activation
of the neuronal centers of the mesolimbic pathway,
including the amygdala (unpublished results).
(6) HFD withdrawal: Mice were given HFD ad libitum all
day for 2 weeks. Then, mice were separated into
two groups: one of them was shifted to regular chow
(n= 3) at 9:00 am and the other remained fed with
HFD (n= 3). All mice were perfused at 9:00 am
after 24 h of HFD withdrawal. The inclusion of this
protocol in the current study was based on the fact
that it has been found an activation of the amygda-
lar CRF system during cocaine withdrawal in
cocaine-trained rats (Erb and Stewart, 1999; Zhou
et al., 2003).
(7) Conditioned HFD aversion: In the mornings of the
ﬁrst and second days, mice were ad libitum
exposed to HFD for 2 h and then injected with LiCl
(150 mM, 12 ml/kg, i.p., n= 6) or saline (n= 3).
On the third day, mice were exposed to HFD for
2 h again and perfused afterward. HFD intake was
signiﬁcantly reduced in the LiCl-treated group as
compared to the saline-treated group, indicating
that LiCl-treated mice developed conditionedaversion to HFD. A similar protocol has been shown
to eﬀectively activate c-Fos in CeA in rats (Spencer
et al., 2012).
(8) Acute restraint stress: Mice were placed in a 50-ml
plastic Falcon tube, which had a small hole drilled
around its base to allow ventilation, and restrained
for 30 min. Then, experimental mice were returned
to their home cages and perfused 1.5 h later
(n= 3). Similar protocols have been shown to
increase c-For expression in several regions of the
brain, including the amygdala in rats (Chen and
Herbert, 1995) and mice (Nomura et al., 2003).
(9) Forced cold swimming stress: Mice were individu-
ally placed during 90 s into polypropylene cylinders
(height 25 cm, diameter 10 cm) containing 15 cm of
water maintained at 0–2 C. Then, experimental
mice were gently dried using paper towels, returned
to their home cages and perfused 2 h later (n= 3).
Forced swim test is a common stressor already
reported to increase c-Fos in the amygdala of rats
(Zhu et al., 2011; Retson et al., 2014). The present
protocol is a variation of one presented elsewhere
(Heinrichs and Koob, 2006).
(10) Ghrelin administration: On the morning of the exper-
imental day, animals were ICV-injected with 4 lL of
acyl-ghrelin (0.6 nmol/mouse, Global Peptide, cat#
PI-G-03, n= 3). Food intake was recorded during
the following 2 h and veriﬁed to signiﬁcantly rise in
the ghrelin-treated group. Mice were perfused
immediately afterward. ICV ghrelin administration
has been shown to activate the amygdala in mice
(Hansson et al., 2014).
(11) Melanocortin 4 receptor (MC4R) agonist adminis-
tration: Mice were ICV-injected with the MC4R ago-
nist RO27–3225 (4 lg/mouse, Sigma–Aldrich, St.
Louis, MO, USA, cat# R3905, n= 3) and perfused
2 h after treatment. This procedure is known to pro-
duce strong c-Fos induction in the amygdaloid com-
plex in mice (Agosti et al., 2014).
All experimental manipulations were performed in
parallel to a set of control mice. Since several of these
control mice were exposed to the same experimental
conditions, they were grouped for the analysis as
follows: (i) control group 1: mice used as control of
stress paradigms (protocols 2, 8 y 9). These mice were
gentle handed for 5 min, introduced for 10 min in a
clean cage, returned to their home cage and perfused
2 h later (n= 6). (ii) control group 2: mice used as
control of feeding paradigms (protocols 4, 5 y 6). These
mice were individually housed, exposed to a pellet of
regular chow inside the home cage and perfused 2 h
later (n= 6). (iii) control group 3: mice used as control
of ICV treatments (protocols 10 y 11). These mice,
which had been stereotaxically implanted with an
indwelling sterile guide cannula a week before the
experiment, were ICV-injected vehicle and perfused 2 h
later (n= 5). Paradigms 1, 3 and 7 had each its own
speciﬁc control group.
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immunohistochemistry
Brains of mice subjected to the diﬀerent experimental
protocols were coronally cut into three equal series on a
sliding cryostat. For c-Fos immuno-staining, sections
were pretreated with H2O2, blocking solution, and
incubated with anti-c-Fos antibody (Calbiochem/
Oncogene, San Diego, CA, USA, cat# PC38, 1:30,000)
for two days at 4 C. Then, sections were treated with
biotinylated donkey anti-rabbit antibody for 1 h, and with
Vectastain Elite ABC kit for 1 h, as described above.
Then, visible signal was developed with DAB/Nickel
solution, giving a black/purple precipitate. Sections were
sequentially mounted on glass slides, and coverslipped
with mounting media. Results were visualized in a Nikon
Eclipse 50i microscope and images were acquired with
a Nikon DS-Ri1 digital camera. The ﬂuorescent hrGFP
signal was conﬁned to the perikarya and dendrites, thus
allowing visualization of the nucleus with or without
black/purple label for c-Fos. The analysis and counting
of c-Fos/hrGFP colocalization for each mouse series
were performed in bregma coordinates ranging from
0.58 to 1.70 mm.Quantitative analysis
Total c-Fos-IR cells were bilaterally quantiﬁed in the
whole amygdala and qualitative estimates of c-Fos-IR
were made by considering both signal strength and the
number of labeled cells. In order to estimate total hrGFP
cells positive for c-Fos, cells containing distinct nuclear
black/purple precipitate in cells with obvious green
signal were bilaterally quantiﬁed in one out of three
complete series of coronal sections through the whole
nuclei. A blinded quantitative analysis was performed
independently by two observers and expressed as total
hrGFP neurons with nuclei positive for c-Fos in both
amygdales.Statistical analyses
Data are expressed as the mean ± SEM. A one-way
ANOVA followed by the Dunnet test was used to
compare the percentage of hrGFP neurons with nuclei
positive for c-Fos from diﬀerent experimental groups to
its corresponding control group, as described above. In
the case where there was a single condition to be
tested against its control group, Student’s t-test was
employed. Signiﬁcant diﬀerences were considered when
p< 0.05. Analyses were performed using GraphPad
Prism 5.0.RESULTS
Validation of CRF-hrGFP mouse model
Transgenic mice expressing hrGFP in CRF-producing
cells were generated by engineering the RP24-80I22
CRF BAC such that hrGFP is driven by CRF regulatory
elements (Fig. 1A). Fluorescence microscopy conﬁrmed
an abundant presence of hrGFP-expressing cells within
the amygdala. In addition, hrGFP-positive cells weredetected in the nucleus accumbens, the bed nucleus of
the stria terminalis, the ventral pallidum, the pontine
reticular nucleus, the periaqueductal gray, the lateral
dorsal tegmental nucleus, and Barrington’s nucleus, all
of which are brain areas known to contain CRF-
expressing neurons (Swanson et al., 1983). In contrast,
we failed to detect hrGFP-expressing cells in the cerebral
cortex, the lateral septum, the substantia innominata, the
preoptic area, the zona incerta, the hippocampus, the
dorsomedial hypothalamus, the raphe magnus, the
peduncular pontine tegmental nucleus, the inferior collicu-
lus, the lateral parabrachial nucleus, the reticulotegmental
nucleus of the pons, the medial vestibular nucleus, the
gigantocellular reticular nucleus, and the inferior olive,
where the presence of scattered CRF-positive cells has
been described (Alon et al., 2009). Notably, only few
hrGFP-expressing cells were found in the PVN of this
transgenic line (not shown). Most importantly, no
hrGFP-positive cells were detected in areas where CRF
gene expression has not been previously reported. To
determine whether hrGFP expression in the amygdala
was restricted to CRF neurons, a histochemical analysis
for hrGFP ﬂuorescence together with CRF immunostain-
ing was performed. The hrGFP ﬂuorescence was very
strong and mainly found in neuron cell bodies, as
expected, but also in the dendrites. The immuno-histo-
chemical visualization of CRF-producing neurons in the
amygdala proved to be particularly diﬃcult: CRF-IR signal
was exclusively found in ﬁbers with no stained cells in the
amygdala of naı¨ve CRF-hrGFP mice, and CRF-IR signal
was also mainly visualized in ﬁbers with only a few faintly
stained cells in the amygdala of CRF-hrGFP mice ICV-
pretreated with colchicine. However, intra-amygdalar
pre-treatment with colchicine was successful, resulting
in the immuno-histochemical visualization of CRF-produc-
ing neuronal cell bodies in the amygdala. Under this con-
dition, CRF-IR signal was mainly conﬁned to the perikarya
and the pattern of hrGFP ﬂuorescence was unaﬀected,
thus allowing estimation of the degree of co-localization
of both ﬂuorescent signals in neurons (Fig. 1B–E). Nearly
100% of CRF-IR amygdalar neurons also expressed
hrGFP, while the 87 ± 12% of green ﬂuorescent amygda-
lar cells also showed CRF-IR red signal.
Detailed neuroanatomical characterization of hrGFP
expression within the amygdala
Next, a more detailed neuroanatomical characterization of
CRF-expressing neurons within the amygdala was
performed. The hrGFP-positive neurons were distributed
between rostro-caudal levels 0.25 and 1.81 mm from
the Bregma of adult CRF-hrGFP mouse brains
(Fig. 2A–C), with most (about 63%) located in a
narrower region between rostro-caudal levels 0.47 and
1.12 mm from the Bregma (Fig. 2B). The hrGFP-
positive cells were observable within the anterior, middle
and caudal portions of the IPAC and the rostral part of
the CeA, but they were completely absent in the BLA
(see below). In order to avoid quenching of the hrGFP
ﬂuorescence signal in the course of the analysis,
chromogenic immunostaining against hrGFP was also
performed. Thus, neuroanatomical characterization was
Fig. 1. Novel CRF-hrGFP mice. Panel A shows a schematic diagram of the derivation of CRF-hrGFP mice. In order to generate the transgene, the
564-bp of CRF’s coding sequence (denoted by a red ﬁlled rectangle) was replaced by the coding sequence of hrGFP followed by an SV40
polyadenylation signal (pA). This speciﬁc transgenic line was derived from the RP24–80I22 CRF BAC. CRF’s and the transgene’s transcriptional
start sites (+1), CRF’s exons (denoted by numbered rectangles outlined in red), and the start codons (ATG) and stop codons (TGA or TAA) for CRF
and hrGFP are all indicated. Panel B shows a schematic diagram of a coronal section of the mouse brain at the level where microphotographs were
taken. Panel C shows low magniﬁcation merge microphotographs of hrGFP and CRF-IR signal within the amygdala of a colchicine-treated CRF-
hrGFP transgenic mouse. Panels D-F show high magniﬁcation microphotographs of the area marked in panel C. Panel D shows hrGFP in green,
panel E shows CRF-IR in red, and panel F shows the merge of both images. White arrows point to dual-labeled cells. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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auto-ﬂuorescence or further ampliﬁcation of the signal
achieved by an anti-hrGFP antibody followed by
biotinylated secondary antibody, streptavidin-peroxidase,
and a chromogenic reaction (Fig. 3). Both ﬂuorescent
and chromogenic signals showed very similar and
consistent patterns of signal. However, chromogenic
immunostaining made positive neurons more evident
because the extra ampliﬁcation steps of the reaction
helped to enhance the signal particularly of faintly green
ﬂuorescent cells (Fig. 3). Thus, chromogenic hrGFP-IR
signal was used for the detailed neuroanatomical
analysis. The hrGFP-IR neurons were predominantly
medium-sized, multipolar cells with intensely stained
hrGFP-IR varicose terminals; and they were observed
with a typical distribution at diﬀerent rostro-caudal levels
the amygdala (Fig. 3). In the anterior and middle levels
of the amygdala, hrGFP-IR neurons were exclusively
observed in the IPAC, mainly surrounding the dorsal
part of the posterior limb of the anterior commissure
(Fig. 3A, B, respectively). In contrast, hrGFP-IR neurons
in the posterior level of the amygdala were observed not
only in the IPAC but also in the CeA (Fig. 3C). On
average, 1991 ± 62 hrGFP-IR neurons were detected
hemilaterally within the amygdala region, with most of
them (92 ± 1%) located within the IPAC.Functional characterization of hrGFP -expressing
neurons of the amygdala in CRF-hrGFP mice
After characterizing the distribution of hrGFP-expressing
neurons within the amygdala, the induction of the
marker of cellular activation c-Fos was assessed in
CRF-hrGFP mice exposed to diﬀerent experimental
paradigms. These procedures were chosen based ontwo criteria: their reported ability to activate the
amygdala, and their potential association with CRF
signaling in this brain region. The performed tests
included: i.p. LPS administration, an acute social defeat
stress paradigm, a fasting/refeeding paradigm, an acute
HFD protocol, an intermittent HFD protocol, a HFD
withdrawal protocol, a conditioned HFD aversion
protocol, an acute restraint stress protocol, a forced cold
swimming stress protocol, ICV ghrelin administration,
and ICV MC4R agonist administration. Firstly, we
conﬁrmed that the total number of c-Fos-IR cells in the
amygdala of all experimental mice subjected to the
diﬀerent protocols was increased as compared to their
corresponding control group, indicating that each
procedure was successful in activating the region of
interest (not shown). Interestingly, only CRF-hrGFP
mice exposed to fasting/refeeding paradigm, acute
social defeated stress or LPS administration showed a
signiﬁcant increase of hrGFP-neurons positive for c-Fos
as compared to the levels found in control mice, the ﬁrst
condition being the one which elicited the strongest
activation (Table 1 and Fig. 4). In all three cases, the
hrGFP neurons positive for c-Fos were distributed
throughout the whole rostro-caudal axis of the
amygdala, without any particular pattern among hrGFP
cells. The presence of these hrGFP neurons positive for
c-Fos was mainly observed in the IPAC region (around
95% of all hrGFP neurons positive for c-Fos) while only
few of them were found in the CeA (around 5% of all
hrGFP neurons positive for c-Fos).DISCUSSION
The current study provides the ﬁrst neuroanatomical
characterization of the distribution of the CRF neurons
Fig. 2. Distribution pattern of hrGFP neurons within the amygdala of CRF-hrGFP mice. Panel A shows a composite of wide-ﬁeld photographs of
every 4th successive coronal brain slices, superimposed with ﬂuorescence microscopy images of the hrGFP signal channel in magenta false
coloring. The corresponding bregma coordinates for each slice are indicated, along with a higher magniﬁcation inset. Panel B shows a plot of the
unilateral number of hrGFP-IR cells per slice in the bregma ranges from 0.25 to 1.81. The values shown are the mean of 4–6 measures, with
their corresponding SEM. Panel C shows diﬀerent views of a 3D reconstruction of the amygdalar region, generated from the whole series shown in
panel A (39 slices in total). The position of every hrGFP-IR cell is marked by a green ball, along with the main white matter tracts [corpus callosum
(cc), external capsule (ec), posterior limb of the anterior commissure (acp), stria terminalis (st), optic tract (opt)], the central amygdala (CeA) and the
external surface of the brain (es). The left image shows a general view from a posterior position. The top and bottom right images show a close-up
view of the amygdalar region from a posterior-medial and an antero-medial position, respectively, with the st and opt omitted for better clarity. Axes
provide orientation of global coordinates: anterior, posterior, ventral, dorsal, medial and lateral.
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mouse line in which the hrGFP is under the control of
the CRF promoter (CRF-hrGFP mice). The current
study also demonstrates that amygdalar CRF neurons
are activated by acute social defeated stress, a fasting/
refeeding paradigm or LPS administration, but not by
other stimuli known to recruit amygdalar neurons.A combination of histochemistry and ﬂuorescence
was used to validate the appropriate expression of
hrGFP within the CRF neurons of the amygdala, and
the majority of CRF neurons showed to express hrGFP.
Notably, few green ﬂuorescent neurons were detected
in the PVN of CRF-hrGFP mice. The exact reasons for
the limited hrGFP expression in the PVN are unclear,
Fig. 3. Detailed pattern distribution of hrGFP neurons within the sub-nuclei of the amygdala of CRF-hrGFP mice. These panels depict a set of
representative images from the anterior (bregma-0.22, Panel A), middle (bregma-0.58, Panel B), and posterior (bregma-1.46, Panel C) levels of
the amygdala containing hrGFP neurons. For each level, a diagram of the corresponding coronal section is shown, with a rectangle indicating the
approximate region from where the images were obtained, along with microphotographs of three consecutive coronal brain slices presented in the
following order from left to right: Thionin-stained section, anti-hrGFP immunohistochemistry section, and hrGFP ﬂuorescence microscopy section.
Every image has an overlay delineating the main histological features present. IPAC: interstitial nucleus of the posterior limb of the anterior
commissure, CPu: caudate putamen, LGP: lateral globus pallidus, acp: posterior limb of the anterior commissure, CeA: central amygdala, ic:
internal capsule, BLA: basolateral amygdala, st: stria terminalis, opt: optic tract.
Table 1. Quantitative analysis of hrGFP neurons positive for c-Fos in
the amygdala of the diﬀerent experimental groups
Experimental condition hrGFP neurons positive for
c-Fos (%)
Control group 1 (non stressed) 0 ± 0
Control group 2 (regular chow
fed)
0 ± 0
Control group 3 (vehicle, ICV) 0 ± 0
Vehicle, i.p. 0 ± 0
LPS, i.p. 5.9 ± 1.2⁄⁄⁄
Acute social defeat stress 7.4 ± 1.6⁄⁄⁄
Fasting/refeeding 10.9 ± 2.3⁄⁄⁄
Fasting 1.4 ± 0.2
Acute HFD 0.6 ± 0.6
Intermittent HFD 1.6 ± 0.5
HFD ad libitum 0 ± 0
HFD withdrawal 0 ± 0
Conditioned HFD aversion 0 ± 0
Control of conditioned HFD
aversion test
0 ± 0
Acute restraint stress 0 ± 0
Forced cold swimming test 0 ± 0
Ghrelin, ICV 0.2 ± 0.1
MC4R agonist RO 27–3225,
ICV
0 ± 0
⁄⁄⁄p< 0.01 vs. corresponding control group.
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eﬀects, failure of insertion of the entire BAC, unintended
eﬀects of removing the CRF coding sequence from the
transgene, and/or lack of critical elements in the BAC
necessaries for PVN gene expression (Matthaei, 2007;
Gama Sosa et al., 2010). Regarding the last possibility,
it is well known that diﬀerent elements of the promoters
can direct expression of the CRF gene in a brain
nucleus-speciﬁc manner (Yoshida, 2008; Kageyama and
Suda, 2009). Despite these considerations, which are
known concerns for all transgenic mouse models, the
CRF-hrGFP mouse described here appears as a useful
tool for studying the role of CRF neurons within the
amygdala.
The amygdala is a structurally and functionally
complex brain region with extensive inter- and intra-
nuclear connections (Sah et al., 2003). The CRF neurons
represent an important neuronal population within the
amygdala, and its physiological role is a focus of intensive
research. Notably, the detailed neuroanatomical localiza-
tion of CRF neurons within the mouse amygdala had not
been performed. Current data show that the CRF-
expressing cells in the amygdala are mainly observed in
the IPAC with a smaller fraction of neurons within the
CeA. Although certain discrepancies exist in terms of
the exact localization of CRF neurons within the rat
Fig. 4. Fasting/refeeding protocol activates amygdala hrGFP neurons in CRF-hrGFP mice. CRF-hrGFP mice were food deprived for 48 h, and then
were either perfused or given access to food for 2 h and then perfused. c-Fos IHC was performed on coronal brain sections, and colocalization for
hrGFP and c-Fos was evaluated by ﬂuorescence and bright-ﬁeld microscopy. Representative images of the amygdala region at bregma 0.58 mm
of a control (panels A-C) and a refed mouse (panels D–F) are shown. Upper and bottom set of panels show ﬂuorescence of hrGFP (left), staining for
c-Fos (middle) and a merge of both (right), along with their corresponding insets at higher magniﬁcation. Colocalization of c-Fos and hrGFP is
indicated by the white arrows. IPAC: interstitial nucleus of the posterior limb of the anterior commissure, CPu: caudate putamen, LGP: lateral globus
pallidus.
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contains the largest number of CRF neurons while other
amygdalar nuclei contain only a small number of such
neurons (Swanson et al., 1983; Bugnon et al., 1984;
Veening et al., 1984; Sakanaka et al., 1986, 1987;
Shimada et al., 1989). In contrast, the largest number of
CRF neurons is found in the basal and lateral nuclei of
the amygdala of the squirrel monkey (Bassett and
Foote, 1992). In mice, and less prominently in rats, CRF
mRNA-reactive neurons were reported antero-dorsal to
the amygdala in the region of the IPAC and in the
amygdalo-striatal transition area, with variations between
the strains (Asan et al., 2005). Thus, the relative distribu-
tion of CRF neurons within the amygdala diﬀers among
species and even within strains of the same species, as
a consequence, data from diﬀerent animal models should
be integrated with caution.
Mapping c-Fos induction has been widely and
successfully used in the past to map neuronal activation
and to determine the participation of speciﬁc neuronal
subsets in diﬀerent neural circuits (Hoﬀman and Lyo,
2002). This has not been the case, however, for the
CRF neurons of the amygdala given their diﬃcult identiﬁ-
cation in a physiologically functional context. In the pres-
ent work we take advantage of this new transgenic CRF
reporter mouse model to gain insights into the involve-
ment of the CRF neurons of the amygdala in the
responses elicited by diﬀerent experimental paradigms,
using c-Fos as a surrogate marker for neuronal activation.
Nonetheless, it is important to stress the fact that the
absence of c-Fos expression in CRF neurons of theamygdala under some experimental conditions, particu-
larly those involving chronic processes, is not proof that
these neurons are not involved in a given response.
(Hoﬀman and Lyo, 2002).
The CRF system of the amygdala has been implicated
in the regulation of aversion and rewarding behaviors
(George et al., 2012; Zorrilla et al., 2014). For instance,
cocaine administration increases both CRF expression
and release in the amygdala (Sarnyai et al., 1993;
Richter et al., 1995; Gardi et al., 1997). Increases in the
activity of the amygdalar CRF system has been also
shown during the early cocaine withdrawal phase in
cocaine-trained rats (Erb and Stewart, 1999; Zhou et al.,
2003). Although less clear, some evidence suggests that
these CRF neurons play a role in the regulation of food-
related rewarding behaviors. It has been shown, for
instance, that amygdala lesions decrease HFD prefer-
ence (King et al., 1998), exposure to palatable foods
induces c-Fos in the CeA (Park and Carr, 1998), and food
intake induces CRF release in the CeA (Merali et al.,
1998). In order to test if the CRF neurons of the amygdala
are recruited by palatable foods, CRF-hrGFP mice were
exposed to a number of paradigms in which HFD was
used as a rewarding stimulus. Analysis of c-Fos induction
showed that CRF neurons failed to increase this marker
of neuronal activation after acute HFD consumption, inter-
mittent HFD consumption, ad libitum HFD consumption,
HFD withdrawal after 2 weeks of ad libitum HFD con-
sumption or conditioned HFD aversion. Notably, c-Fos
in the amygdala was signiﬁcantly increased under all
these experimental conditions suggesting that the
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neuronal populations of the amygdala seem to be
recruited by these conditions. As stated above, the
absence of c-Fos induction within the CRF neurons of
the amygdala when HFD consumption was manipulated
is not proof of the absence of their engagement in a given
neuronal circuit. However, the fact that c-Fos increase
within CRF neurons in response to other stimulus does
support the possibility that these neurons of the amygdala
play a rather minor role on these HFD-related behaviors.
It is well-known that the CRF system of the amygdala
is involved in stress responses (LeDoux, 2007; Kova´cs,
2013). Here, we conﬁrmed that acute social defeat stress,
restraint stress, immune challenge, and forced swim
stress all elicited an increase of c-Fos levels in the amyg-
dala, as previously reported (Dayas et al., 2001; Martinez
et al., 2002). However, c-Fos induction in the CRF neu-
rons of the amygdala was detected only in response to
speciﬁc challenges. Exposure of CRF-hrGFP mice to
the forced cold swim stress or acute restraint stress,
which are both experimental models for psychological
stress (Glavin et al., 1994), failed to activate c-Fos in
the CRF neurons of the amygdala. In contrast, CRF-
hrGFP mice exposed to either acute social defeat stress
or immune challenge showed a robust increase of the
c-Fos expression in the CRF neurons of the amygdala.
A single event in the resident–intruder paradigm of social
defeat, in which the experimental animal is exposed to a
non-lethal aggression, is suﬃcient to induce behavioral
changes that persist for weeks, and the CRF system of
the amygdala has been show to modulate agonistic
behavior following social defeat (Tornatzky and Miczek,
1993; Meerlo et al., 1999; Jasnow et al., 2004; Robison
et al., 2004). Thus, the current results conﬁrm that the
CRF neurons of the amygdala are recruited by acute
social defeat stress. On the other hand, it has been sug-
gested that the amygdala mediates LPS eﬀects on a num-
ber of brain functions, including reduction of exploratory
behaviors toward novel objects (Haba et al., 2012). In
fact, administration of LPS triggers activation of the CeA
mediated by vagal stimulation, and induces depressive-
like behaviors in rats (Konsman et al., 2000). Current data
point at the CRF neurons of the amygdala as a target of
the neuronal systems activated by an immune challenge.
Overall, these observations show that the CRF neurons of
the amygdala play a diﬀerential role in response to
diverse experimental conditions, supporting the notion
that the neuronal circuits engaged by stress within the
amygdala are stressor-speciﬁc.
The amygdala is known to be involved in food intake
regulation (Baxter and Murray, 2002; Will et al., 2009).
The MC4R, which mediates anorexigenic eﬀects provided
by the pro-opiomelanocortin-derived peptide a-melano-
cyte stimulating hormone, is highly expressed in the
amygdala (Kishi et al., 2003), and central administration
of an MC4R agonist strongly increases c-Fos expression
in the amygdala (Agosti et al., 2014). The key role of the
amygdala in mediating the anorectic eﬀects of the MC4R
signaling is highlighted by the ﬁnding that the re-expres-
sion of MC4R exclusively in the PVN and amygdala is suf-
ﬁcient to restore food intake and partially prevent obesityin MC4R-deﬁcient mice (Balthasar et al., 2005). The cur-
rent study shows, however, that MC4R agonist adminis-
tration to CRF-hrGFP mice fails to activate c-Fos in the
CRF neurons of the amygdala suggesting that other neu-
ronal populations of the amygdala mediate the anorexic
eﬀect of MC4R signaling in this brain area. Interestingly,
the amygdala has also been shown to be a target of the
orexigenic hormone ghrelin. In particular, the amygdala
has been suggested to mediate ghrelin’s roles in the mod-
ulation of food reward and learning (Alvarez-Crespo et al.,
2012). Indeed, a human functional MRI study showed that
ghrelin activates the amygdala upon exposure to images
of appealing foods (Malik et al., 2008), and ghrelin recep-
tor is expressed in the amygdala (Mani et al., 2014).
Despite that a signiﬁcant increase of c-Fos was detected
in the amygdala of ghrelin-treated mice, no c-Fos was
detected in the CRF neurons of this brain region also sug-
gesting that other neuronal populations of the amygdala
mediate ghrelin’s eﬀects.
Food intake regulation involves the integration of
orexigenic and anorexigenic neuronal circuits that drive
or stop feeding, respectively, depending on the energy
needs. Fasting activates orexigenic neuronal pathways
that drive hyperphagia when animals have access to
food, while refeeding activates neuronal pathways
involved in the termination of a meal (Grill and Kaplan,
2002). It is well established that brainstem and hypotha-
lamic pathways have a critical role in the regulation of
meal size. However, recent evidences also show that
other brain regions, including the amygdala, are important
in acute appetite regulation (Wu et al., 2014). In particular,
a recent study using genetically encoded anatomical,
optogenetic and pharmacogenetic tools have showed that
a parabrachial nucleus–amygdala pathway is essential to
suppress appetite after refeeding (Carter et al., 2013).
However, the phenotype of the amygdalar neurons acti-
vated by refeeding is unknown. The current study not only
conﬁrms that refeeding after fasting activates c-Fos in the
amygdala, as previously reported (Timofeeva et al., 2002;
Wu et al., 2014), but also shows that CRF neurons of the
amygdala are one of the neuronal cell types activated in
this condition. In line with this possibility, it had been
shown that CRF mRNA levels in the amygdala decreased
during food deprivation and gradually returned to pre-
deprivation values during refeeding in rats (Timofeeva
et al., 2002). Furthermore, microdialysis experiments
have shown a rise in amygdalar CRF during the prandial
and postprandial phases of a spontaneous meal in rats
(Merali et al., 1998), a pattern congruent with a potential
suppressive role of CRF on feeding. It is interesting to
note, however, that the physiological role of CRF as an
anorectic peptide has been a matter of debate. Central
administration of CRF potently inhibits food intake in
rodents, and the CRF system has been suggested to play
an essential role as mediator of stress-induced anorexia
(Koob and Heinrichs, 1999; Richard et al., 2002; Zorrilla
et al., 2003). However, CRF-deﬁcient mice display a sim-
ilar decrease in food intake when compared to wild-type
mice under the same stress conditions (i.e. repetitive daily
restraint, turpentine abscess or surgical stress), which
may highlight the importance of other members of the
P. N. De Francesco et al. / Neuroscience 289 (2015) 153–165 163CRF system (such as urocortins) as mediators of appetite
reduction (Weninger et al., 1999). These seemingly
antagonizing results may also reﬂect the complexity of
this regulatory system, stressing the importance of the
local context of action of these peptides and its develop-
mental adaptative mechanisms. In the current study, acti-
vation of the CRF neurons of the amygdala was also
detected after LPS administration or acute social defeat,
two experimental conditions which also decrease food
intake (Meerlo et al., 1999; Konsman et al., 2000).
Although it would be tempting to draw a parallelism with
the fasting/refeeding paradigm in this regard, caution
should be exerted when performing generalizations, as
other paradigms that failed to induce c-Fos in CRF neu-
rons of the amygdala, such as acute restraint or forced
swimming, also suppress food intake. Overall, current
data suggest a link between CRF neurons of the amyg-
dala and food intake suppression after some particular
experimental conditions; however, more studies will be
necessary to speciﬁcally test this possibility. Hopefully,
the CRF-hrGFP mouse model reported here will be a
useful tool to perform further studies that will help to
clarify the physiological role of the CRF system of the
amygdala.
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